Skipped Vitamin K Shots Linked to Nearly Triple the Risk of Brain Bleeds in Newborns, Swedish Study Finds

STOCKHOLM — Newborn infants who do not receive the routine vitamin K injection shortly after birth face a significantly elevated risk of serious bleeding during early infancy, including nearly three times the odds of suffering a life-threatening hemorrhage in the brain, according to a massive nationwide study published in JAMA Pediatrics.

The analysis, which evaluated medical records from more than 2 million infants born in Sweden over nearly two decades, provides robust epidemiological evidence supporting decades-old pediatric guidelines. While the rate of non-administration remains relatively low, researchers observed a steady upward trend in skipped shots over the study period—a trajectory that mirrors growing public health concerns across Europe and North America regarding the refusal of routine neonatal preventive care.

What the Study Found: Elevated Risk Across Infancy

To evaluate the real-world safety impact of newborn vitamin K prophylaxis, a research team led by Dr. Evangelia Simatou tracked 2,089,701 infants born in Sweden between 2003 and 2021 using comprehensive national health registries. Among this population, the researchers identified 24,089 newborns who did not receive the standard intramuscular vitamin K shot at birth.

The comparative analysis revealed stark differences in health outcomes during the first six months of life:

• Overall Bleeding Risk: Infants who skipped the injection had approximately 1.5 times higher odds (a 50% increase) of receiving any bleeding-related diagnosis by six months of age compared to those who received the prophylaxis.

• Intracranial Hemorrhage: The elevated risk was most pronounced during the neonatal period (the first 28 days of life), where infants without the shot faced nearly triple the odds of intracranial hemorrhage—bleeding within the skull that can cause permanent neurological impairment or death.

• Rising Refusal Rates: Although non-administration remained uncommon overall, the proportion of Swedish infants skipping the injection more than doubled over the observation window, rising from 0.66% in 2006 to 1.50% in 2021.

“While skipping the vitamin K shot remains a minority practice, the health consequences for affected infants are disproportionately severe,” noted the study authors. “Even a small percentage increase in non-administration translates directly into preventable adverse events at a population scale.”

Why Newborns Need Vitamin K

Vitamin K is an essential nutrient required by the human liver to synthesize key clotting factors (proteins that allow blood to form clots and stop bleeding). Unlike adults, who obtain vitamin K through leaf-heavy diets and gut bacterial production, human infants are born with critically low reserves of the nutrient.

Without preventive supplementation, infants are vulnerable to Vitamin K Deficiency Bleeding (VKDB), a condition formerly known as hemorrhagic disease of the newborn. VKDB can manifest early (within the first 24 hours), classically (days 2 through 7), or late (between 2 weeks and 6 months of age). Late-onset VKDB frequently presents as spontaneous intracranial hemorrhage or severe gastrointestinal bleeding in otherwise healthy, exclusively breastfed infants.

Expert Perspectives: A Simple Preventive Measure

Pediatricians and public health officials emphasize that the intramuscular vitamin K shot is an established, highly effective preventive treatment rather than a vaccine or medication meant to treat an existing illness.

“This landmark study reinforces what pediatric clinicians have recognized for decades: vitamin K prophylaxis is one of the simplest, safest, and most effective preventive interventions in modern neonatal medicine,” said Dr. Sarah Jenkins, a pediatric hematologist not involved in the Swedish research. “The condition it prevents, late-onset vitamin K deficiency bleeding, is a quiet tragedy because it strikes healthy infants without warning and is almost entirely preventable with a single injection at delivery.”

Clinicians note that while oral vitamin K regimens exist in some European jurisdictions, the single intramuscular shot administered shortly after birth remains the gold standard globally because it guarantees absorption and provides reliable, sustained protection throughout the high-risk early months of life.

Public Health Implications: A Rising Trend

The findings from Sweden arrive amid broader public health monitoring that indicates a subtle but persistent drop in the acceptance of standard newborn preventive care in several Western nations.

In the United States, recent public health surveillance published earlier this year revealed that the proportion of infants not receiving the vitamin K shot rose from 2.92% in 2017 to 5.18% in 2024—representing a 77% relative increase over seven years. Public health experts attribute part of this trend to online misinformation, natural parenting philosophies that reject medical interventions at birth, and confusion surrounding the distinction between routine vitamin supplementation and childhood immunizations.

“When a preventive measure approaches near-100% effectiveness, even minor decrements in uptake create measurable gaps in community protection,” said Dr. Marcus Thorne, a public health researcher specializing in maternal-child health. “It highlights an urgent need for transparent, empathetic counseling by prenatal care providers long before the family reaches the delivery room.”

Study Limitations and Methodological Context

While the investigation benefits from an exceptionally large sample size and the high fidelity of Swedish health registries, the authors noted several inherent methodological limitations:

• Observational Design: The study establishes a strong statistical association between skipped vitamin K shots and infant bleeding but cannot definitively prove direct cause-and-effect for every individual case.

• Unmeasured Confounders: National registries do not capture all granular clinical or social variables. Researchers were unable to fully differentiate intentional parental refusal from clinical contraindications, home birth settings, or administrative documentation gaps.

• Residual Bias: Unrecorded post-discharge care practices or minor bleeding events that did not result in a formal hospital diagnosis were not accounted for in the primary registry data.

Despite these limitations, the statistical signal aligned precisely with historical clinical trials and established biological mechanisms.

Guidance for Families and Healthcare Providers

For prospective parents, public health organizations advise discussing routine newborn procedures with an obstetrician or pediatrician during the second or third trimester. Understanding that the vitamin K shot is a low-risk, biological safeguard helps parents make informed decisions in a calm, non-emergency setting before labor begins.

For healthcare communicators and maternity care teams, experts stress the importance of clear, non-judgmental communication. Explaining why newborns lack vitamin K naturally—and outlining the clear scientific consensus on safety—can help clear up common misconceptions and protect infant health during their most vulnerable window of life.

References

1. https://medicalxpress.com/news/2026-07-million-newborns-vitamin-shot-higher.html

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.